IDEAYA Biosciences Nominates IDE251 for Targeting Amplified Tumors in Breast and Lung Cancer IDEAYA Biosciences has nominated IDE251, a potential KAT6/7 dual inhibitor aimed at treating breast and lung cancers associated with 8p11 amplification.

IDEAYA Biosciences Nominates IDE251 for Targeting Amplified Tumors in Breast and Lung Cancer #USA #South_San_Francisco #IDEAYA #IDE251 #KAT6/7